Abionyx : A new generation biotech company - 2017 Annual Results and Update on TANGO

EN
FR

Home
About
- About
- Abionyx
- Management
- Board of Directors
- Specialized Committees
  
  - Audit Committee
  - Remuneration Committee
- Scientific Advisory Board
Our Assets
- Our Assets
- CER 001
- CER 002
- CER 209
Indications
Media
- Media
- Press releases
- ABIONYX in the media
- Videos
Investors

Fichier: PR_cerenis_RN_2017_EN.pdf